Back

SGLT2 inhibitors in diabetes with CKD

1 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Diabetes Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Assistant Professor Aaqib H Malik

Catholic Medical Center, Manchester (United States of America)

14 More presentations in this session

Presentation thumbnail
Professor F. Schiele (Besancon, FR)
Abstract
Presentation thumbnail
Doctor A. Antonopoulos (Athens, GR)
Abstract
Presentation thumbnail
Assistant Professor B. Parapid (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Doctor A. Antonopoulos (Athens, GR)
Abstract
Presentation thumbnail
Professor Z. Kobalava (Moscow, RU)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Diabetes

The Event

Event poster

ESC Congress 2019

1 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Chronic kidney disease and diabetes status do not affect efficacy of SGLT-2 inhibitors in patients with heart failure with reduced ejection fraction
29 June 2021
thumbnail
Congress Session
Optimising cardiovascular risk prediction and management in patients with renal disease
4 April 2025
thumbnail
Congress Presentation
Patient vascular model reveals anti-inflammatory effects of SGLT2 inhibitor by modulating endothelial-T cell crosstalk
31 August 2025
thumbnail
Congress Presentation
Treatment with SGLT2 inhibitors in the early phase post acute myocardial infarction
15 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources